Nixon Peabody Trust’s Procter & Gamble PG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.6M | Sell |
92,565
-2,140
| -2% | -$311K | 0.96% | 27 |
|
|
2026
Q1 | $13.7M | Sell |
94,705
-3,425
| -3% | -$519K | 1.09% | 27 |
|
|
2025
Q4 | $14.1M | Sell |
98,130
-859
| -0.9% | -$127K | 1.06% | 27 |
|
|
2025
Q3 | $15.2M | Sell |
98,989
-752
| -0.8% | -$117K | 1.11% | 25 |
|
|
2025
Q2 | $15.9M | Sell |
99,741
-444
| -0.4% | -$72.5K | 1.23% | 26 |
|
|
2025
Q1 | $17.1M | Sell |
100,185
-664
| -0.7% | -$111K | 1.45% | 19 |
|
|
2024
Q4 | $16.9M | Buy |
100,849
+853
| +0.9% | +$145K | 1.39% | 23 |
|
|
2024
Q3 | $17.3M | Buy |
99,996
+679
| +0.7% | +$115K | 1.44% | 23 |
|
|
2024
Q2 | $16.4M | Sell |
99,317
-2,900
| -3% | -$474K | 1.46% | 21 |
|
|
2024
Q1 | $16.6M | Buy |
102,217
+3,857
| +4% | +$605K | 1.52% | 22 |
|
|
2023
Q4 | $14.4M | Buy |
98,360
+84,474
| +608% | +$12.5M | 1.62% | 23 |
|
|
2023
Q3 | $2.03M | Buy |
13,886
+100
| +0.7% | +$15.3K | 1.7% | 27 |
|
|
2023
Q2 | $2.09M | Sell |
13,786
-289
| -2% | -$43.6K | 1.7% | 20 |
|
|
2023
Q1 | $2.09M | Sell |
14,075
-2,229
| -14% | -$319K | 1.46% | 31 |
|
|
2022
Q4 | $2.47M | Sell |
16,304
-70
| -0.4% | -$9.81K | 2% | 14 |
|
|
2022
Q3 | $2.07M | Sell |
16,374
-12,850
| -44% | -$1.83M | 1.75% | 18 |
|
|
2022
Q2 | $4.2M | Sell |
29,224
-2,634
| -8% | -$396K | 1.9% | 16 |
|
|
2022
Q1 | $4.87M | Sell |
31,858
-4,687
| -13% | -$733K | 1.68% | 21 |
|
|
2021
Q4 | $5.98M | Buy |
36,545
+2,477
| +7% | +$368K | 1.81% | 19 |
|
|
2021
Q3 | $4.76M | Buy |
34,068
+1,339
| +4% | +$190K | 1.72% | 25 |
|
|
2021
Q2 | $4.42M | Buy |
32,729
+82
| +0.3% | +$11.1K | 1.7% | 28 |
|
|
2021
Q1 | $4.42M | Buy |
32,647
+270
| +0.8% | +$35.2K | 1.79% | 24 |
|
|
2020
Q4 | $4.5M | Sell |
32,377
-933
| -3% | -$130K | 1.9% | 21 |
|
|
2020
Q3 | $4.63M | Buy |
33,310
+317
| +1% | +$42.1K | 2.13% | 16 |
|
|
2020
Q2 | $3.94M | Buy |
32,993
+390
| +1% | +$45.5K | 2% | 18 |
|
|
2020
Q1 | $3.59M | Buy |
32,603
+914
| +3% | +$110K | 2.22% | 14 |
|
|
2019
Q4 | $3.96M | Buy |
31,689
+172
| +0.5% | +$21K | 1.97% | 22 |
|
|
2019
Q3 | $3.92M | Sell |
31,517
-2,235
| -7% | -$264K | 2.09% | 18 |
|
|
2019
Q2 | $3.7M | Buy |
33,752
+4,720
| +16% | +$503K | 2.09% | 20 |
|
|
2019
Q1 | $3.02M | Buy |
29,032
+2,098
| +8% | +$204K | 1.98% | 25 |
|
|
2018
Q4 | $2.48M | Buy |
26,934
+541
| +2% | +$48.4K | 1.95% | 23 |
|
|
2018
Q3 | $2.2M | Buy |
26,393
+1,895
| +8% | +$155K | 1.5% | 34 |
|
|
2018
Q2 | $1.91M | Buy |
24,498
+2,724
| +13% | +$205K | 1.48% | 34 |
|
|
2018
Q1 | $1.73M | Buy |
21,774
+395
| +2% | +$32.9K | 1.55% | 34 |
|
|
2017
Q4 | $1.97M | Buy |
21,379
+241
| +1% | +$21.7K | 1.69% | 32 |
|
|
2017
Q3 | $1.92M | Buy |
21,138
+30
| +0.1% | +$2.73K | 1.75% | 30 |
|
|
2017
Q2 | $1.84M | Sell |
21,108
-445
| -2% | -$39.2K | 1.7% | 30 |
|
|
2017
Q1 | $1.94M | Sell |
21,553
-855
| -4% | -$75.8K | 1.82% | 25 |
|
|
2016
Q4 | $1.88M | Sell |
22,408
-365
| -2% | -$31.1K | 1.83% | 26 |
|
|
2016
Q3 | $2.04M | Sell |
22,773
-5,143
| -18% | -$447K | 2.01% | 19 |
|
|
2016
Q2 | $2.36M | Sell |
27,916
-273
| -1% | -$22.4K | 2.05% | 14 |
|
|
2016
Q1 | $2.32M | Sell |
28,189
-385
| -1% | -$31K | 2.06% | 14 |
|
|
2015
Q4 | $2.27M | Buy |
+28,574
| New | +$2.18M | 2.07% | 14 |
|
Other funds holding PG
JIC
RG
FAF
Nixon Peabody Trust's PG Position: Q2 2026 in Review
Nixon Peabody Trust reduced its Procter & Gamble (PG) stake by 2.3% in Q2 2026, selling an estimated $311K and leaving 92,565 shares worth $13.6M. The position accounts for 0.96% of the portfolio, ranked #27.
Nixon Peabody Trust first reported a position in PG in Q4 2015 and has held it in 43 quarters since. The position peaked at $17.3M in Q3 2024. 1,650 funds tracked by Wall St. Rank hold PG as of Q2 2026.
- Nixon Peabody Trust held 92,565 shares of Procter & Gamble worth $13.6M as of Q2 2026.
- Nixon Peabody Trust sold 2,140 Procter & Gamble shares in Q2 2026, an estimated $311K.
- Procter & Gamble made up 0.96% of Nixon Peabody Trust's portfolio in Q2 2026, its #27 holding.
- Nixon Peabody Trust first reported a position in Procter & Gamble in Q4 2015 and has held it in 43 quarters since.
- Nixon Peabody Trust's Procter & Gamble position peaked at $17.3M in Q3 2024.
- 1,650 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.
Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.